Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Leukemia
|
January 12, 2019
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
A Dodero, A Guidetti, A Tucci, et al.
Leukemia
|
June 29, 2007
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P Corradini, A Dodero, L Farina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
A Necchi, L Mariani, M Di Nicola, et al.
Bone Marrow Transplantation
|
January 21, 2014
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis
M Magni, M Di Nicola, C Patti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 25, 2020
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019)
A J P Clover, F de Terlizzi, G Bertino, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Leukemia
|
January 12, 2019
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
A Dodero, A Guidetti, A Tucci, et al.
Leukemia
|
June 29, 2007
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P Corradini, A Dodero, L Farina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
A Necchi, L Mariani, M Di Nicola, et al.
Bone Marrow Transplantation
|
January 21, 2014
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis
M Magni, M Di Nicola, C Patti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 25, 2020
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019)
A J P Clover, F de Terlizzi, G Bertino, et al.
Page
of 5